1st Quarter - Report

FAEGRE DRINKER BIDDLE & REATH LLP for INTERNATIONAL PHARMACEUTICAL AEROSOL CONSORTIUM

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Environment/Superfund ENV

Environmental (climate change) impact of medical propellants for metered dose inhalers, including HFC-134a and HFC-227ea in connection with House Ways and Means Committee inquiry on topic.

Foreign entity interest: The foreign entities affiliated with the registrant manufacture metered dose inhalers and would be impacted by the above issue.

LobbyistCovered position, as disclosed
MAUREEN HARDWICK —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
BOEHRINGER INGELHEIM Germany Germany — —
TEVA Ireland Ireland — —
CIPLA India India — —

Affiliated organisations

OrganisationLocation
CIPLA Warren, NJ, US
KINDEVA Woodbury, MN, US
ORGANON Jersey City, NJ, US
TEVA Parsippany, NJ, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.